This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
South Asia, is the southern region of the Asian continent, which comprises the sub-Himalayan countries including Bangladesh,
Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka. It is home to well over one fifth of the world's population, thus is
the most densely populated geographical region in the world. This Region includes the countries that were part of the former
British Empire including India, Pakistan, and Bangladesh at the core, but also including Sri Lanka, Burma. The Drug Regulations
developed by the British during their rule in this region are still the bases of Drug Regulation in these countries. The common
issues are a colonial mindset of bureaucracy, lack of resources for capacity building of regulatory authorities/MOH. But the
prevailing law gives immense powers to the bureaucrats in these authorities. With new emerging regulations for Pharmaceutical,
Medical Devices and Biological Drugs in the developed world, a need for having the same set of regulations is felt by the regulators
as well. But the resource constraints and lack of training in emerging of relevant regulations is either nonexistent or painstakingly
slow and the authorities are trying to manage in unique ways. Thus becoming a challenge for Regulatory Affairs Professionals as
the authorities are coming up with novel ideas nonexistent elsewhere.. To tap the immense potential of this huge market the issues
in regulation of the drugs shall be addressed for the benefit of all.
Nadeem Alamgir started his carrier as a Sales Representative in MSD in 1985. He grew over the years in sales in different Pharmaceutical firms and
then switched to Regulatory Affairs. While working as regulatory affairs professional he worked with the Government of Pakistan for Pharmaceutical
Sector Reforms and amendment of The Drugs Act 1976 of Pakistan, formulation of regulations for Biological Drugs and Medical Devices Regulation.
He was instrumental for membership of Pakistan Asian Harmonization Working Party (AHWP) and was able to motivate the authorities to create a
separate Medical Device and Biological Drugs department in Drugs Regulatory Agency of Pakistan. He is also the Non Regulatory Primary Member
of (AHWP) Asian Harmonization Working Party.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals